1. Home
  2. PRPO vs FOXO Comparison

PRPO vs FOXO Comparison

Compare PRPO & FOXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • FOXO
  • Stock Information
  • Founded
  • PRPO N/A
  • FOXO 2019
  • Country
  • PRPO United States
  • FOXO United States
  • Employees
  • PRPO N/A
  • FOXO N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • FOXO Retail: Computer Software & Peripheral Equipment
  • Sector
  • PRPO Industrials
  • FOXO Technology
  • Exchange
  • PRPO Nasdaq
  • FOXO Nasdaq
  • Market Cap
  • PRPO 9.9M
  • FOXO 4.9M
  • IPO Year
  • PRPO N/A
  • FOXO N/A
  • Fundamental
  • Price
  • PRPO $7.22
  • FOXO $0.24
  • Analyst Decision
  • PRPO
  • FOXO
  • Analyst Count
  • PRPO 0
  • FOXO 0
  • Target Price
  • PRPO N/A
  • FOXO N/A
  • AVG Volume (30 Days)
  • PRPO 5.9K
  • FOXO 9.1M
  • Earning Date
  • PRPO 03-28-2025
  • FOXO 11-19-2024
  • Dividend Yield
  • PRPO N/A
  • FOXO N/A
  • EPS Growth
  • PRPO N/A
  • FOXO N/A
  • EPS
  • PRPO N/A
  • FOXO N/A
  • Revenue
  • PRPO $17,411,000.00
  • FOXO $1,341,000.00
  • Revenue This Year
  • PRPO $75.18
  • FOXO N/A
  • Revenue Next Year
  • PRPO N/A
  • FOXO N/A
  • P/E Ratio
  • PRPO N/A
  • FOXO N/A
  • Revenue Growth
  • PRPO 31.31
  • FOXO 196.03
  • 52 Week Low
  • PRPO $4.31
  • FOXO $0.13
  • 52 Week High
  • PRPO $7.55
  • FOXO $1.30
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 62.56
  • FOXO 46.29
  • Support Level
  • PRPO $7.02
  • FOXO $0.20
  • Resistance Level
  • PRPO $7.55
  • FOXO $0.23
  • Average True Range (ATR)
  • PRPO 0.25
  • FOXO 0.02
  • MACD
  • PRPO 0.05
  • FOXO 0.00
  • Stochastic Oscillator
  • PRPO 73.78
  • FOXO 52.70

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About FOXO FOXO Technologies Inc.

FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.

Share on Social Networks: